Luqiong Cai
Wenzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Idebenone attenuates RANKL-induced osteoclastogenesis and improves bone mass in ovariectomized mice.
Idebenone attenuates RANKL-induced osteoclastogenesis and improves bone mass in ovariectomized mice.
Journal: Free radical biology & medicine
Published: May 14, 2025
Catharanthine tartrate ameliorates osteoclastogenesis by destabilizing HIF-1α.
Journal: Cellular signalling
Published: January 03, 2025
Corrigendum to "GPR37 promotes cancer growth by binding to CDK6 and represents a new theranostic target in lung adenocarcinoma"[Pharmacol. Res. 183 (2022) 106389].
Journal: Pharmacological research
Published: September 06, 2024
Tetrahydroberberine Prevents Ovariectomy-Induced Bone Loss by Inhibiting RANKL-Induced Osteoclastogenesis and Promoting Osteoclast Apoptosis.
Journal: Journal of agricultural and food chemistry
Published: September 05, 2024
Hexahistidine-metal assembly encapsulated fibroblast growth factor 21 for lipopolysaccharide-induced acute lung injury.
Journal: European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V
Published: August 01, 2024
Fibroblast Growth Factor 21 Relieves Lipopolysaccharide-Induced Acute Lung Injury by Suppressing JAK2/STAT3 Signaling Pathway.
Journal: Inflammation
Published: February 19, 2023
GPR37 promotes cancer growth by binding to CDK6 and represents a new theranostic target in lung adenocarcinoma.
Journal: Pharmacological research
Published: April 15, 2022
Dihydroartemisinin Attenuates Hypoxia-Induced Pulmonary Hypertension Through the ELAVL2/miR-503/PI3K/AKT Axis.
Journal: Journal of cardiovascular pharmacology
Published: January 18, 2022
FGF21 alleviates pulmonary hypertension by inhibiting mTORC1/EIF4EBP1 pathway via H19.
Journal: Journal of cellular and molecular medicine
Published: December 31, 2021
FGF21 attenuates pulmonary arterial hypertension via downregulation of miR-130, which targets PPARγ.
FGF21 attenuates pulmonary arterial hypertension via downregulation of miR-130, which targets PPARγ.
Journal: Journal of cellular and molecular medicine
Published: July 24, 2021
FGF21 attenuates hypoxia‑induced dysfunction and inflammation in HPAECs via the microRNA‑27b‑mediated PPARγ pathway.
Journal: International journal of molecular medicine
Published: November 13, 2020
Elucidation of the Mechanisms and Molecular Targets of Qishen Yiqi Formula for the Treatment of Pulmonary Arterial Hypertension using a Bioinformatics/Network Topology-based Strategy.
Journal: Combinatorial chemistry & high throughput screening
Published: May 22, 2020
Last Updated: 09/26/2026